Author:
Kim Seok-Ki,Kim Sung Eun,Chung June-Key,Kim E. Edmund
Reference62 articles.
1. Soper JT. Radiographic imaging in gynecologic oncology. Clin Obstet Gynecol. 2001;44:485–94.
2. Vardi J, Tadros G, Foemmel R, Shebes M. Plasma lipid-associated sialic acid and serum CA125 as indicators of disease status with ovarian cancer. Obstet Gynecol. 1989;73:379–83.
3. Gupta NC, Frank AR, Casey MJ. FDG PET imaging for post-treatment evaluation of patients with genitourinary malignancies. J Nucl Med. 1992;33:829.
4. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1999;49:8–31.
5. Chou CY, Chang CH, Yao BL, et al. Color Doppler ultrasonography and serum CA125 in the differentiation of benign and malignant ovarian tumors. J Clin Ultrasound. 1994;22:491–6.